Cumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line ResultsPRNewsWire · 1 day ago
CUMBERLAND PHARMACEUTICALS PROVIDES UPDATED WEBCAST REGISTRATION LINK FOR IFETROBAN DMD PROGRAM CALLPRNewsWire · 1 day ago
CUMBERLAND PHARMACEUTICALS ANNOUNCES NATIONAL CALL TO PRESENT AN UPDATE ON ITS IFETROBAN DMD PROGRAMPRNewsWire · 5 days ago
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Crosses Above 200 Day Moving Average – What’s Next?Defense World · Sep 24, 2026
Contrasting ANI Pharmaceuticals (NASDAQ:ANIP) and Cumberland Pharmaceuticals (NASDAQ:CPIX)Defense World · Sep 11, 2026
Cumberland Pharmaceuticals: Pivot Into Drug Development Creates Risk, OpportunitySeeking Alpha · Aug 13, 2026Cumberland Pharmaceuticals Inc. functions as a specialized pharmaceutical enterprise, primarily involved in the procurement, advancement, and commercialization of prescription medications. Its strategic focus areas include acute hospital care, gastroenterology, rheumatology, and oncology, with operations spanning both the United States and global markets. The company's existing product line includes: Acetadote: an injectable solution for treating acetaminophen poisoning.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 4, 2026 | -$0.13 | -$0.20 | Miss |
| May 5, 2026 | -$0.13 | -$0.13 | Beat |
| Mar 3, 2026 | -$0.13 | -$0.01 | Beat |
| Nov 4, 2025 | -$0.13 | -$0.06 | Beat |
| Aug 5, 2025 | – | $0.02 | |
| May 6, 2025 | -$0.01 | $0.16 | Beat |